| 000 | 01551 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513074421.0 | ||
| 264 | 0 | _c19931020 | |
| 008 | 199310s 0 0 eng d | ||
| 022 | _a0022-1767 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVan Strijp, J A | |
| 245 | 0 | 0 |
_aLigand specificity of purified complement receptor type three (CD11b/CD18, alpha m beta 2, Mac-1). Indirect effects of an Arg-Gly-Asp (RGD) sequence. _h[electronic resource] |
| 260 |
_bJournal of immunology (Baltimore, Md. : 1950) _cSep 1993 |
||
| 300 |
_a3324-36 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBinding, Competitive |
| 650 | 0 | 4 | _aCations, Divalent |
| 650 | 0 | 4 |
_aComplement C3b _xmetabolism |
| 650 | 0 | 4 |
_aFatty Acids _xmetabolism |
| 650 | 0 | 4 |
_aFibrinogen _xmetabolism |
| 650 | 0 | 4 |
_aHemagglutinins _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aIntegrins _xmetabolism |
| 650 | 0 | 4 |
_aLeishmania mexicana _xmetabolism |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 |
_aMacrophage-1 Antigen _xisolation & purification |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 |
_aNeutrophils _xmetabolism |
| 650 | 0 | 4 | _aOligopeptides |
| 650 | 0 | 4 |
_aPeptides _xmetabolism |
| 700 | 1 | _aRussell, D G | |
| 700 | 1 | _aTuomanen, E | |
| 700 | 1 | _aBrown, E J | |
| 700 | 1 | _aWright, S D | |
| 773 | 0 |
_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 151 _gno. 6 _gp. 3324-36 |
|
| 999 |
_c8376053 _d8376053 |
||